Loading…
GeroNova Research Inc. was cited for marketing unapproved and misbranded drugs—specifically CARNITINE PLUS Vegcaps, Liquid L-Carnitine, and R-Lipoic Acid Vegcaps—through Amazon and social media platforms. The company violated the Federal Food, Drug, and Cosmetic Act by making disease claims (including references to treating mitochondrial dysfunction, autism, cardiomyopathy, and metabolic disorders) that established these products as drugs lacking FDA approval. The violations occurred across the company's Amazon storefront, Facebook page, Twitter account, and website, all of which were interconnected to direct consumers to purchase the products.